NEW YORK, Sept. 20, 2005 (PRIMEZONE) -- NanoViricides, Inc. (Other OTC:NNVC.PK - News) announced today that the Company is actively developing its first NanoViricide(tm) drug, ``FluCide-I(tm).'' The Company expects to commence studies in external laboratories within a matter of weeks to verify the drug's effectiveness and basic safety profile against the influenza virus. Animal studies as well as cell culture studies will be initiated.